Life Science News

big data ieee

Cloud DX's Chief Medical Officer Joins IEEE SA Telehealth Working Groups and Executive Team Update

News in Summary

  • Dr. Sonny Kohli, Cloud DX's chief medical officer and a critical care physician at Oakville Trafalgar Memorial Hospital, will advise the IEEE SA Telehealth IC Working Groups on establishing world-wide standards for telehealth and virtual care.
  • Government regulators, including Health Canada and the US FDA, often use IEEE standards as a requirement when approving new technologies for sale.
  • The chance to guide the development of international industry standards is another example of Cloud DX's acknowledged innovation and thought leadership in the field of virtual care.
  • Cloud DX CFO Stephanie Bird is transitioning out of Cloud DX effective Sept 30, 2021 to pursue a new opportunity.

Cloud DX (TSXV:CDX)(OTCQB:CDXFF), a leading North American provider of virtual care and remote patient monitoring solutions is pleased to announce that the company's Chief Medical Officer, Dr. Sonny Kohli has joined the IEEE SA Telehealth IC Working Groups, a new IEEE industrial connections program developing technical standards for novel telehealth technologies

As a global community the IEEE SA Telehealth IC working group will seek to create internationally applicable standards for telehealth and virtual care adoption. These standards will then be used by regulatory agencies like Health Canada and the US FDA to vet and approve the innovative new technologies to come.

The chance to influence and inform the creation of global standards will allow Cloud DX to have an even greater impact on the delivery of virtual care around the world.

"I am honoured to contribute to this important IEEE program and I look forward to sharing with this prestigious international working group the lessons we've learned at Cloud DX," stated Dr. Sonny Kohli, Chief Medical Officer, Cloud DX. "Being asked to participate in efforts to standardize digital healthcare is a testament to the industry's perception of Cloud DX as a leader in remote care. Clients that value excellence view this as one of our differentiators in the marketplace."

Dr. Keith Thompson, Chief Medical Officer at iTelemed and an IEEE SA telehealth IC working group member, adds "We are pleased to have Dr. Kohli join us in the IEEE SA Telehealth IC Working Groups. We need input from industry leaders already disrupting this space including professionals like Dr. Kohli who are passionate about making health care equitable around the world. Cloud DX has been on an incredible trajectory of growth given the accelerated interest in RPM systems during COVID. Sonny has been an inspiration for me personally and it is truly a milestone for our IEEE SA IC team to be able to work alongside him as we create the future standards for telehealth adoption".

Executive Team Update

CFO Stephanie Bird has elected to leave the company for a new opportunity with a private Toronto-based company, effective September 30, 2021. Cloud DX wishes to thank Ms. Bird for all her incredible hard work as we completed our go-public process in 2021, we wish her every success in her new role and we are pleased to work with her on an orderly transition. The company is currently engaged in a selection process to choose a new CFO on or before October 1, 2021.

About Cloud DX

Accelerating virtual healthcare's future,Cloud DX is making healthcare better for everyone. The company's Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable ageing in place and deliver hospital-quality post-surgical care. Providers partnering with Cloud DX achieve better healthcare and patient outcomes, reduce the need for hospitalization/re-hospitalization and reduce the costs of healthcare delivery through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist and one of "Canada's Ten Most Prominent Telehealth Providers."

About IEEE SA

The Institute of Electrical and Electronics Engineers Standards Association (IEEE SA) is an operating unit within IEEE that develops global standards in a broad range of industries, including power and energy, artificial intelligence systems, internet of things, consumer technology and consumer electronics, biomedical and health care, information technology, robotics, telecommunication, home automation, automotive, transportation, nanotechnology, and many more. IEEE SA is not a body formally authorized by any government, but rather a community that provides a neutral platform that unites communities for standards development and technological innovation and is independent of any government oversight. IEEE SA develops standards that are consensus-based and offer balance, openness, and fair procedures. Technical experts from all over the world participate in the development of IEEE standards.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Social Links

Twitter: https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/
Instagram https://www.instagram.com/cloud.dx/

For media inquiries, please contact:

Ellyn Winters-Robinson
Ignition Communications (PR for Cloud DX)
519-574-2196
ellyn@ignition.ca

For investor inquiries please contact:

Jay Bedard
Cloud DX Investor Relations
647-881-8418
jay.bedard@CloudDX.com

SOURCE: Cloud DX Inc.



View source version on accesswire.com:
https://www.accesswire.com/661816/Cloud-DXs-Chief-Medical-Officer-Joins-IEEE-SA-Telehealth-Working-Groups-and-Executive-Team-Update

News Provided by ACCESSWIRE via QuoteMedia

Alkaline Fuel Cell Power Corp. Announces the Closing of New Credit Facilities and Update on the Previously Announced Private Placement

Alkaline Fuel Cell Power Corp. Announces the Closing of New Credit Facilities and Update on the Previously Announced Private Placement

Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB:ALKFF) (Frankfurt: 77R, WKN: A3CTYF) (" PWWR " or the " Company "), a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech, is pleased to announce that it has entered into a credit agreement (the " Credit Agreement ") with Juno Financial Group Corporation (" Juno ") for a fixed rate loan to the Company for a gross amount of approximately CAD $800,000 (the " Loan "). The entire Loan amount will be provided to the Company immediately and is expected to be used for general corporate purposes.

"We are pleased to be working with Juno with their cleantech experience, and we saw the loan as a more immediate opportunity to fund our current needs, thus postponing our private placement," stated Frank Carnevale, Chief Executive Officer."

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Avricore Health Corporate Update - Earnings Advisory 2022 and 2023 Objectives

Avricore Health Corporate Update - Earnings Advisory 2022 and 2023 Objectives

Avricore Health INC. (TSXV: AVCR) (the " Company " or " AVCR ") is entering the second year of a multi-year growth plan to bring HealthTab, its turnkey solution for point of care testing and data management, to more pharmacies across Canada and the world. As part of this effort the Company is pleased to provide insight into the successes of last year and lay out updates and objectives on further progress.

"Last year we set out bold targets and today we can demonstrate we've been able to achieve them," said Hector Bremner, CEO of Avricore Health Inc. "There's no doubt that we are poised for significant growth in 2023 and beyond."

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
E-Power Resources Announces Director Change

E-Power Resources Announces Director Change

E-Power Resources Inc (CSE: EPR) ("E-Power" or the "Company") announces that Ms. Anna Oxenstierna has resigned from the board of directors of the Company, and the board has accepted her resignation. The Company thanks Ms. Oxenstierna for her contributions and wishes her well on her future endeavors.

The Company is currently in discussions with suitable candidates to replace Ms. Oxenstierna. An announcement will be made in due course.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Alkaline Fuel Cell Power Corp. Announces AGM Results

Alkaline Fuel Cell Power Corp. Announces AGM Results

Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB:ALKFF) (Frankfurt: 77R, WKN: A3CTYF) ("AFCP" or the "Company") a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech, is pleased to announce the results of voting at its annual general meeting (" AGM ") of shareholders which was held on January 25, 2023 in person in Vancouver, British Columbia and by conference call (the " Meeting "). There were 19 shareholders represented in person or by proxy at the Meeting holding 2,423,369 common shares, representing 1.39% of the Company's total issued and outstanding common shares as at the record date for the Meeting. The voting results for each matter presented at the Meeting is set out below:

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Alkaline Fuel Cell Power Announces Resignation of Director

Alkaline Fuel Cell Power Announces Resignation of Director

Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB:ALKFF) (Frankfurt: 77R, WKN: A3CTYF) ("AFCP" or the "Company") a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech, announces the resignation of Joel Dumaresq as director, effective January 12, 2023. Mr. Dumaresq will remain as the Chief Financial Officer of the Company while the Company seeks a suitable replacement.

ABOUT Alkaline Fuel Cell Power CORP.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
BriaCell CEO Letter to Shareholders

BriaCell CEO Letter to Shareholders

  • Positive FDA feedback on our pivotal study for lead clinical candidate Bria-IMT™ in combination with a checkpoint inhibitor could greatly accelerate the path to commercialization.
  • Successful completion of the pivotal study could be followed by a Biologics License Application submission and commercialization.
  • Pivotal study's primary endpoint to be linked to survival improvement.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, today issues a letter to shareholders from Dr. William V. Williams, BriaCell's President and CEO.

Dear BriaCell Shareholders,

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×